A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Clinical trial NCT03290950 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03290950
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2025-05-21
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.